{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:23:12Z","timestamp":1794849792453,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01529-y","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:03:18Z","timestamp":1761296598000},"page":"1373-1391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9917-7804","authenticated-orcid":false,"given":"Tingting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaolin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-0751","authenticated-orcid":false,"given":"Zihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunzhi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-9965","authenticated-orcid":false,"given":"Qingbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-8632","authenticated-orcid":false,"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-9180","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-6214","authenticated-orcid":false,"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7028-6220","authenticated-orcid":false,"given":"Junyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-634X","authenticated-orcid":false,"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-4212","authenticated-orcid":false,"given":"Zizheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-2800","authenticated-orcid":false,"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-1038","authenticated-orcid":false,"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"1529_CR1","doi-asserted-by":"crossref","unstructured":"Ellis, R. W. & Brown, K. R. Combination Vaccines (Academic Press, 1997).","DOI":"10.1016\/S1054-3589(08)60077-0"},{"key":"1529_CR2","first-page":"00092","volume":"S2214-109X","author":"WP Hausdorff","year":"2024","unstructured":"Hausdorff, W. P. et al. Facilitating the development of urgently required combination vaccines. Lancet Glob. Health S2214-109X, 00092\u201300095 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1529_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0974-777X.77298","volume":"3","author":"DAG Skibinski","year":"2011","unstructured":"Skibinski, D. A. G., Baudner, B. C., Singh, M. & O\u2019Hagan, D. T. Combination vaccines. J. Glob. Infect. Dis. 3, 63\u201372 (2011).","journal-title":"J. Glob. Infect. Dis."},{"key":"1529_CR4","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","volume":"11","author":"K Maman","year":"2015","unstructured":"Maman, K. et al. The value of childhood combination vaccines: from beliefs to evidence. Hum. Vaccines Immunother. 11, 2132\u20132141 (2015).","journal-title":"Hum. Vaccines Immunother."},{"key":"1529_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","volume":"25","author":"H Kalies","year":"2006","unstructured":"Kalies, H. et al. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr. Infect. Dis. J. 25, 507\u2013512 (2006).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1529_CR6","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1016\/j.vaccine.2017.07.051","volume":"36","author":"F Kowalzik","year":"2018","unstructured":"Kowalzik, F., Faber, J. & Knuf, M. MMR and MMRV vaccines. Vaccine 36, 5402\u20135407 (2018).","journal-title":"Vaccine"},{"key":"1529_CR7","first-page":"S6","volume":"9","author":"D Dodd","year":"2003","unstructured":"Dodd, D. Benefits of combination vaccines: effective vaccination on a simplified schedule. Am. J. Manag. Care 9, S6\u2013S12 (2003).","journal-title":"Am. J. Manag. Care"},{"key":"1529_CR8","doi-asserted-by":"publisher","first-page":"591580","DOI":"10.1155\/2015\/591580","volume":"2015","author":"S Esposito","year":"2015","unstructured":"Esposito, S. & Principi, N. Impacts of the 13-valent pneumococcal conjugate vaccine in children. J. Immunol. Res. 2015, 591580 (2015).","journal-title":"J. Immunol. Res."},{"key":"1529_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ijgo.12075","volume":"136","author":"L Mariani","year":"2017","unstructured":"Mariani, L., Preti, M., Cristoforoni, P., Stigliano, C. M. & Perino, A. Overview of the benefits and potential issues of the nonavalent HPV vaccine. Int. J. Gynecol. Obstet. 136, 258\u2013265 (2017).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"1529_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq0839","volume":"377","author":"AA Cohen","year":"2022","unstructured":"Cohen, A. A. et al. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. Science 377, eabq0839 (2022).","journal-title":"Science"},{"key":"1529_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735\u2013741 (2021).","journal-title":"Science"},{"key":"1529_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-021-03594-0","volume":"594","author":"KO Saunders","year":"2021","unstructured":"Saunders, K. O. et al. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature 594, 553\u2013559 (2021).","journal-title":"Nature"},{"key":"1529_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 53, 1315\u20131330.e1319 (2020).","journal-title":"Immunity"},{"key":"1529_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","volume":"592","author":"S Boyoglu-Barnum","year":"2021","unstructured":"Boyoglu-Barnum, S. et al. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature 592, 623\u2013628 (2021).","journal-title":"Nature"},{"key":"1529_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba6466","volume":"5","author":"KA Swanson","year":"2020","unstructured":"Swanson, K. A. et al. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. Sci. Immunol. 5, eaba6466 (2020).","journal-title":"Sci. Immunol."},{"key":"1529_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell 183, 1367\u20131382.e1317 (2020).","journal-title":"Cell"},{"key":"1529_CR17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2021.01.035","volume":"184","author":"PJM Brouwer","year":"2021","unstructured":"Brouwer, P. J. M. et al. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell 184, 1188\u20131200.e1119 (2021).","journal-title":"Cell"},{"key":"1529_CR18","doi-asserted-by":"publisher","first-page":"e136653","DOI":"10.1172\/jci.insight.136653","volume":"5","author":"HG Kelly","year":"2020","unstructured":"Kelly, H. G. et al. Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight 5, e136653 (2020).","journal-title":"JCI Insight"},{"key":"1529_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat. Nanotechnol. 15, 406\u2013416 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"1529_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00622-0","volume":"8","author":"C Jacob-Dolan","year":"2023","unstructured":"Jacob-Dolan, C. et al. Immunogenicity and protective efficacy of GBP510\/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques. npj Vaccines 8, 23 (2023).","journal-title":"npj Vaccines"},{"key":"1529_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"F-C Zhu","year":"2010","unstructured":"Zhu, F.-C. et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376, 895\u2013902 (2010).","journal-title":"Lancet"},{"key":"1529_CR22","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","volume":"67","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2. Sci. Bull. 67, 1372\u20131387 (2022).","journal-title":"Sci. Bull."},{"key":"1529_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6230","volume":"371","author":"P-A Koenig","year":"2021","unstructured":"Koenig, P.-A. et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 371, eabe6230 (2021).","journal-title":"Science"},{"key":"1529_CR24","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","volume":"23","author":"SW Li","year":"2005","unstructured":"Li, S. W. et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23, 2893\u20132901 (2005).","journal-title":"Vaccine"},{"key":"1529_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","volume":"403","author":"S Huang","year":"2024","unstructured":"Huang, S. et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 403, 813\u2013823 (2024).","journal-title":"Lancet"},{"key":"1529_CR26","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1074\/jbc.M410361200","volume":"280","author":"S-W Li","year":"2005","unstructured":"Li, S.-W. et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J. Biol. Chem. 280, 3400\u20133406 (2005).","journal-title":"J. Biol. Chem."},{"key":"1529_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1406011","volume":"372","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Long-term efficacy of a hepatitis E vaccine. N. Engl. J. Med. 372, 914\u2013922 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","volume":"11","author":"S-W Li","year":"2015","unstructured":"Li, S.-W. et al. The development of a recombinant hepatitis E vaccine HEV 239. Hum. Vaccines Immunother. 11, 908\u2013914 (2015).","journal-title":"Hum. Vaccines Immunother."},{"key":"1529_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0006-8","volume":"2","author":"X Huang","year":"2017","unstructured":"Huang, X., Wang, X., Zhang, J., Xia, N. & Zhao, Q. Escherichia coli-derived virus-like particles in vaccine development. npj Vaccines 2, 3 (2017).","journal-title":"npj Vaccines"},{"key":"1529_CR30","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.mcpro.2024.100865","volume":"23","author":"PC Fridy","year":"2024","unstructured":"Fridy, P. C., Rout, M. P. & Ketaren, N. E. Nanobodies: from high-throughput identification to therapeutic development. Mol. Cell. Proteom. 23, 100865 (2024).","journal-title":"Mol. Cell. Proteom."},{"key":"1529_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101692","volume":"55","author":"H Zare","year":"2021","unstructured":"Zare, H. et al. Nanobodies, the potent agents to detect and treat the coronavirus infections: a systematic review. Mol. Cell. Probes 55, 101692 (2021).","journal-title":"Mol. Cell. Probes"},{"key":"1529_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/pro.2213","volume":"22","author":"C Yang","year":"2013","unstructured":"Yang, C. et al. Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts. Protein Sci. 22, 314\u2013326 (2013).","journal-title":"Protein Sci."},{"key":"1529_CR33","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2217\/nnm-2016-0146","volume":"11","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. A shared N-terminal hydrophobic tail for the formation of nanoparticulates. Nanomedicine 11, 2289\u20132303 (2016).","journal-title":"Nanomedicine"},{"key":"1529_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37237-x","volume":"14","author":"X Sun","year":"2023","unstructured":"Sun, X., Zhou, C., Xia, S. & Chen, X. Small molecule-nanobody conjugate induced proximity controls intracellular processes and modulates endogenous unligandable targets. Nat. Commun. 14, 1635 (2023).","journal-title":"Nat. Commun."},{"key":"1529_CR35","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1073\/pnas.1101309108","volume":"108","author":"X Tang","year":"2011","unstructured":"Tang, X. et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc. Natl Acad. Sci. USA 108, 10266\u201310271 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1529_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.tibtech.2013.09.002","volume":"31","author":"Q Zhao","year":"2013","unstructured":"Zhao, Q., Li, S., Yu, H., Xia, N. & Modis, Y. Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends Biotechnol. 31, 654\u2013663 (2013).","journal-title":"Trends Biotechnol."},{"key":"1529_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/cr.2015.34","volume":"25","author":"Y Gu","year":"2015","unstructured":"Gu, Y. et al. Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res. 25, 604\u2013620 (2015).","journal-title":"Cell Res."},{"key":"1529_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9143","volume":"6","author":"A Krarup","year":"2015","unstructured":"Krarup, A. et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat. Commun. 6, 8143 (2015).","journal-title":"Nat. Commun."},{"key":"1529_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"1529_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25997-3","volume":"12","author":"T Li","year":"2021","unstructured":"Li, T. et al. Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants. Nat. Commun. 12, 5652 (2021).","journal-title":"Nat. Commun."},{"key":"1529_CR41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"1529_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva, N. S. & Klein, U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 15, 137\u2013148 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1529_CR43","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.immuni.2021.07.015","volume":"54","author":"C Young","year":"2021","unstructured":"Young, C. & Brink, R. The unique biology of germinal center B cells. Immunity 54, 1652\u20131664 (2021).","journal-title":"Immunity"},{"key":"1529_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471\u2013482 (2016).","journal-title":"Immunity"},{"key":"1529_CR45","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.chom.2022.10.011","volume":"30","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine. Cell Host Microbe 30, 1732\u20131744.e1737 (2022).","journal-title":"Cell Host Microbe"},{"key":"1529_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg1143","volume":"13","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters. Sci. Transl. Med. 13, eabg1143 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1529_CR47","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1016\/j.vaccine.2014.05.064","volume":"32","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin\u00ae. Vaccine 32, 4039\u20134050 (2014).","journal-title":"Vaccine"},{"key":"1529_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"1529_CR49","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","volume":"193","author":"AM Didierlaurent","year":"2014","unstructured":"Didierlaurent, A. M. et al. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells. J. Immunol. 193, 1920\u20131930 (2014).","journal-title":"J. Immunol."},{"key":"1529_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/IAI.00977-07","volume":"76","author":"S Pichyangkul","year":"2008","unstructured":"Pichyangkul, S. et al. Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S\/AS01B vaccine in rhesus primates. Infect. Immun. 76, 229\u2013238 (2008).","journal-title":"Infect. Immun."},{"key":"1529_CR51","doi-asserted-by":"publisher","first-page":"G67","DOI":"10.1016\/j.vaccine.2009.10.013","volume":"27","author":"J Vekemans","year":"2009","unstructured":"Vekemans, J., Leach, A. & Cohen, J. Development of the RTS,S\/AS malaria candidate vaccine. Vaccine 27, G67\u2013G71 (2009).","journal-title":"Vaccine"},{"key":"1529_CR52","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/v11060508","volume":"11","author":"EA van Erp","year":"2019","unstructured":"van Erp, E. A. et al. Pathogenesis of respiratory syncytial virus infection in BALB\/c mice differs between intratracheal and intranasal inoculation. Viruses 11, 508 (2019).","journal-title":"Viruses"},{"key":"1529_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos, S., Gupta, A. & Ravetch, J. V. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 20, 633\u2013643 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1529_CR54","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1016\/j.vaccine.2021.01.055","volume":"39","author":"FM Munoz","year":"2021","unstructured":"Munoz, F. M. et al. Vaccine-associated enhanced disease: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 39, 3053\u20133066 (2021).","journal-title":"Vaccine"},{"key":"1529_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46\u201361 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1529_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56302-1","volume":"16","author":"M Lin","year":"2025","unstructured":"Lin, M. et al. A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus. Nat. Commun. 16, 1386 (2025).","journal-title":"Nat. Commun."},{"key":"1529_CR57","doi-asserted-by":"publisher","first-page":"110558","DOI":"10.1016\/j.celrep.2022.110558","volume":"38","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants. Cell Rep. 38, 110558 (2022).","journal-title":"Cell Rep."},{"key":"1529_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21503-x","volume":"12","author":"L Chang","year":"2021","unstructured":"Chang, L. et al. The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Nat. Commun. 12, 1383 (2021).","journal-title":"Nat. Commun."},{"key":"1529_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32926-5","volume":"13","author":"T Li","year":"2022","unstructured":"Li, T. et al. Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses. Nat. Commun. 13, 5182 (2022).","journal-title":"Nat. Commun."},{"key":"1529_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/v11010064","volume":"11","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. An optimized high-throughput neutralization assay for hepatitis E virus (HEV) involving detection of secreted Porf2. Viruses 11, 64 (2019).","journal-title":"Viruses"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01529-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:02:28Z","timestamp":1784239348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01529-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1529"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01529-y","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L., T.L., W.X., Y. Gu, J.Z. and N.X. are inventors on a patent application (PCT\/CN2023\/129973) filed by the Xiamen University that covers nanobody mediating the p239 particle decoration described in this work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}